دورية أكاديمية

Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial

التفاصيل البيبلوغرافية
العنوان: Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial
المؤلفون: Lonial, Sagar, Weiss, Brendan M, Usmani, Saad Z, Singhal, Seema, Chari, Ajai, Bahlis, Nizar J, Belch, Andrew, Krishnan, Amrita, Vescio, Robert A, Mateos, Maria Victoria, Mazumder, Amitabha, Orlowski, Robert Z, Sutherland, Heather J, Bladé, Joan, Scott, Emma C, Oriol, Albert, Berdeja, Jesus, Gharibo, Mecide, Stevens, Don A, LeBlanc, Richard, Sebag, Michael, Callander, Natalie, Jakubowiak, Andrzej, White, Darrell, de la Rubia, Javier, Richardson, Paul G, Lisby, Steen, Feng, Huaibao, Uhlar, Clarissa M, Khan, Imran, Ahmadi, Tahamtan, Voorhees, Peter M
المصدر: The Lancet ; volume 387, issue 10027, page 1551-1560 ; ISSN 0140-6736
بيانات النشر: Elsevier BV
سنة النشر: 2016
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
مصطلحات موضوعية: General Medicine
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/s0140-6736(15)01120-4
الإتاحة: https://doi.org/10.1016/s0140-6736Test(15)01120-4
https://api.elsevier.com/content/article/PII:S0140673615011204?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0140673615011204?httpAccept=text/plainTest
حقوق: https://www.elsevier.com/tdm/userlicense/1.0Test/
رقم الانضمام: edsbas.E902AEBC
قاعدة البيانات: BASE